DKSH Extends Collaboration With Bristol-Myers Squibb

DKSH Business Unit Healthcare has extended the relationship started in 2010 with Bristol-Myers Squibb, covering six markets in Asia (Hong Kong, Malaysia, Singapore, Taiwan, Thailand and Vietnam).

Under the new agreements, DKSH will provide marketing, sales, warehousing, physical distribution, credit management and collection services for Bristol-Myers Squibb in certain markets. These agreements memorialize the renewal of the existing regional relationship between Bristol-Myers Squibb and DKSH and underline the growing need of healthcare companies to reduce the number of service providers they work with in each region to limit complexity and increase the possibilities for interaction on a Pan-Asian level.

"We are delighted to extend our regional relationship with Bristol-Myers Squibb in six Asian markets and look forward to helping Bristol-Myers Squibb grow their business with our integrated commercial and distribution platform," commented Thomas Delemazure, Regional Business Development Director Pharmaceuticals, Business Unit Healthcare, DKSH.

DKSH said, the agreement "will further strengthen DKSH's market position in Asia while contributing incrementally to the Group's overall profitability over time."